AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
2.680
-0.060 (-2.19%)
At close: Oct 1, 2025, 4:00 PM EDT
2.680
0.00 (0.00%)
After-hours: Oct 1, 2025, 6:15 PM EDT
AIM ImmunoTech Market Cap
AIM ImmunoTech has a market cap or net worth of $7.58 million as of October 1, 2025. Its market cap has decreased by -74.33% in one year.
Market Cap
7.58M
Enterprise Value
9.55M
1-Year Change
-74.33%
Ranking
n/a
Category
Stock Price
$2.68
Market Cap Chart
Since January 29, 2018, AIM ImmunoTech's market cap has decreased from $17.94M to $7.58M, a decrease of -57.76%. That is a compound annual growth rate of -10.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 7.58M | -41.17% |
| Dec 31, 2024 | 12.88M | -39.50% |
| Dec 29, 2023 | 21.29M | -52.81% |
| Dec 28, 2021 | 45.12M | -51.57% |
| Dec 21, 2020 | 93.17M | 419.24% |
| Jan 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.21B |
| Johnson & Johnson | 437.40B |
| AbbVie | 394.23B |
| UnitedHealth Group | 312.62B |
| Novo Nordisk | 245.50B |
| Novartis AG | 240.62B |
| Abbott Laboratories | 231.67B |
| AstraZeneca | 231.02B |